Skip to main content
SpringerLink
Log in
Book cover

Treatment of Thyroid Tumor pp 57–60Cite as

CQ7. What Are the Blood Chemistry Data That Increase the Likelihood of Thyroid Malignancy and What Are Their Sensitivity, Specificity, and Likelihood Ratio?

  • Chapter
  • First Online:

  • 1337 Accesses

Abstract

Of the possible diagnostic markers of thyroid cancer, CEA and calcitonin have been established as diagnostic markers for medullary carcinoma since the 1970s [1, 2]. TSH and thyroglobulin, which have been evaluated as possible markers, are also discussed.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Pacini F, Fontanelli M, Fugazzola L et al (1994) Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab 78:826–829 (PS)

    Article  PubMed  CAS  Google Scholar 

  2. Iacobone M, Niccoli-Sire P, Sebag F et al (2002) Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels. World J Surg 26:886–890 (PS)

    Article  PubMed  Google Scholar 

  3. Mirallie E, Iacobone M, Sebag F et al (2004) Results of surgical treatment of sporadic medullary thyroid carcinoma following routine measurement of serum calcitonin. Eur J Surg Oncol 30: 790–795 (PS)

    Article  PubMed  CAS  Google Scholar 

  4. Copper DS, Doherty GM, Haugen BR et al (2006) Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16:109–142 (SR<RS>)

    Article  Google Scholar 

  5. Machens A, Ukkat J, Hauptmann S et al (2007) Abnormal carcinoembryonic antigen levels and medullary thyroid cancer progression: a multivariate analysis. Arch Surg 142:289–293 (RS)

    Article  PubMed  CAS  Google Scholar 

  6. Boelaert K, Horacek J, Holder RL et al (2006) Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metab 91:4295–4301 (PS)

    Article  PubMed  CAS  Google Scholar 

  7. Polyzos SA, Kita M, Efstathiadou Z et al (2008) Serum thyrotropin concentration as a biochemical predictor of thyroid malignancy in patients presenting with thyroid nodules. J Cancer Res Clin Oncol 134:953–960 (RS)

    Article  PubMed  CAS  Google Scholar 

  8. Besic N, Sesek M, Peric B et al (2008) Predictive factors of carcinoma in 327 patients with follicular neoplasm of the thyroid. Med Sci Monit 14:CR459–CR467 (RS)

    PubMed  Google Scholar 

  9. Hocevar M, Auersperg M (1998) Role of serum thyroglobulin in the pre-operative evaluation of follicular thyroid tumours. Eur J Surg Oncol 24:553–557 (RS)

    Article  PubMed  CAS  Google Scholar 

  10. Hashimoto T, Mizugami T, Michigishi T et al (1989) (Text in Japanese) Rinsho Byori 37:122–130 (RS)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Organ Regulation Surgery, Fukushima Medical University, School of Medicine, 1 Hikarigaoka, Fukushima, 960-1295, Japan

    Shinichi Suzuki

  2. Department of Surgery, Showa University Northern Yokohama Hospital, Yokohama, Japan

    Nobuhiro Fukunari

  3. Department of Diagnostic Pathology, Keio University School of Medicine, Tokyo, Japan

    Kaori Kameyama

  4. Endocrine Center, Toranomon Hospital, Tokyo, Japan

    Megumi Miyakawa

  5. Department of Breast and Thyroid Surgery, Kawasaki Medical School, Kurashiki, Japan

    Katsuhiro Tanaka

  6. Department of Endocrine Surgery, Fujita Health University School of Medicine, Toyoake, Japan

    Yatsuka Hibi

Authors
  1. Shinichi Suzuki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nobuhiro Fukunari
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kaori Kameyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Megumi Miyakawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Katsuhiro Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yatsuka Hibi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shinichi Suzuki .

Editor information

Editors and Affiliations

  1. Ito Hospital, 4-3-6 Jinguumae, Shibuya-ku, Tokyo, 150-8308, Japan

    Hiroshi Takami

  2. , Department of Surgery, Kuma Hospital, 8-2-35 Shimoyamate-dori, Chuo-ku, Kobe, 650-0011, Japan

    Yasuhiro Ito

  3. Noguchi Thyroid Clinic and Hospital Foun, 6-33 Noguchinaka-machi, Beppu, 874-0932, Japan

    Hitoshi Noguchi

  4. , Department of Breast and Endocrine Surge, Kanagawa Cancer Center, 1-1-2 Nakao, Asahi-ku, Yokohama, 241-8515, Japan

    Akira Yoshida

  5. , Department of Endocrine Surgery, Tokyo Women's Medical University, 8-1 Kawada- cho, Shinjuku-ku, Tokyo, 162-8666, Japan

    Takahiro Okamoto

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Japan

About this chapter

Cite this chapter

Suzuki, S., Fukunari, N., Kameyama, K., Miyakawa, M., Tanaka, K., Hibi, Y. (2013). CQ7. What Are the Blood Chemistry Data That Increase the Likelihood of Thyroid Malignancy and What Are Their Sensitivity, Specificity, and Likelihood Ratio?. In: Takami, H., Ito, Y., Noguchi, H., Yoshida, A., Okamoto, T. (eds) Treatment of Thyroid Tumor. Springer, Tokyo. https://doi.org/10.1007/978-4-431-54049-6_12

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-54049-6_12

  • Published:

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-54048-9

  • Online ISBN: 978-4-431-54049-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation